| Diagnostics |
|
|
|
Articles
(Click on the title to open the article; right-click on mouse to download)
2010
Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol 2010; 45:133-138.
Veijola LI, Oksanen AM, Sipponen PI, Rautelin HIK. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol 2010; 16(1): 83-88.
2009
Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption and chronic atrophic gastritis: Population-based study among
9,444 older adults from Germany. Int J Cancer 2009; 125:2918–2922.
Ghamghro I, Basu S, Vidyarthi M, McTaggert C, Hollanders D. The Incidence of Lactose Deficiency in an endoscopically and histologically normal group of white Caucasians. Gastroenterology Today 2009; 19(3):76-78.
Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009;15(7):853-859.
Ren JS, Kamangar F, Qiao YL, Taylor P, Liang H, Dawsey S, Liu B, Fan JH, Abnet C. Serum pepsinogens and risk of gastric and esophageal cancers in the General Population. Gut. 2009; 58:636-642.
van Marrewijk CJ, van Oijen MGH, Paloheimo LI, Fransen GAJ, Mujakovic S, Muris JWM, Numans ME, de Wit NJ, Grobbee DE, Knottnerus J, Laheij RJF, Jansen JBMJ. Influence of gastric mucosal status on empirical dyspepsia treatment success. Am J Gastroenterol 2009, in press.
2008
Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, Willich SN, Stolte M, Hocker M, Jaspersen D, Lind T, Malfertheiner P. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther 2008; 28(4):491-6.
Sun LP, Gong YH, Wang L, Gong W, Yuan Y. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay. J Dig Dis. 2008 Feb;9(1):20-6
Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Bessonov PP, Vasil'ev RR, Tatarinova OV, Muchina EG. Prevalence of atrophic gastritis in different populations in Siberia on medical evidence of the serological survey. Klin Med (Mosk). 2008;86(7):35-8. [Article in Russian]
de Vries AC, van Driel HF, Richardus JH, Ouwendijk M, van Vuuren AJ, de Man RA, Kuipers EJ. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. Scand J Gastroenterol. 2008;43(4):403-9.
Pimanov SI, Makarenko EV. Potentialities of a serological method in diagnosis of atrophic gastritis. Ter Arkh 2008: 80(2); 15-21. [Article in Russian]
Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. J Gastroenterol Hepatol 2008; 23: 1666-1671.
Shak JR, Roper J, Perez-Perez GI, Tseng CH, Francois F, Gamagaris Z, Patterson C, Weinshel E, Fielding GA, Ren C, Blaser MJ. Research article.The Effect of Laparoscopic Gastric Banding Surgery on Plasma Levels of Appetite-Control, Insulinotropic, and Digestive Hormones. Obes Surg 2008.Subbotin AM. Opportunities of gastroscopy and diagnostic panel "GastroPanel" in diagnosis and treatment of precancer lesions of gastric mucous. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A126.
Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M and Agréus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol; 43:1448-1455.
2007
Sun LP, Gong YH, Wang L, Yuan Y. Serum pepsinogen levels and their influencing factors: A population-based study in 6990 Chinese from North China. World J Gastroenterol 2007 December 28; 13(48): 6562-6567
van Oijen MGH, Sipponen P, Laheij RJF, Verheugt FWA, Jansen JBMJ. Gastric status and vitamin B12 levels in cardiovascular patients. Dig Dis Sci 2007; 52(9):2186-2189.
Minushkin OV, Zverkov IV, Topchii TB, Volodin PV, Shuleshova AG. Chronic autoimmune gastritis: diagnosis and features of the disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A101.troenterology, Hepatology, Coloproctology 2007; 5:A95.
Kurilovich SA, Reshetnikov OV, Krotov SA, Krotova VA, Bessonov PP, Vasielev RR. Atrophic gastritis in two Siberian populations: serological screening. Russian Journal of Gas
Ilchishina TA. Influence of HP-infection diagnostic choice on evaluation of efficiency of eradication therapy. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A79.
Ivanova LM, Kudinov NA, Nabatchikov GB, Lozovator AL, Razlivaeva NI, Terenkov VK. GastroPanel - clinical and morphological comparision. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A78.
Backlanova OA. Diagnosis of precancer lesions of stomach in group of patients selected by non-invasive screening of atrophic gastritis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A57.
Backlanova OA. Opportunities of non-invasive screening of atrophic gastritis as precancer lesion of stomach. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A56.
Akimanko EI, Lubanskaya TG, Prohozheva AU, Omelchenko OV. Diagnosis of gastrobiopsy and serological methods in diagnosis of gastric mucous pathology. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2007; 5:A50.
Drygina LB, Bigeldina NA. ”GastroPanel” test in stomach diseases diagnostics. Clinico-Laboratory Consilium 2007; 18:55-65.
Rethetnikov OV, Kurilovich SA, Krotov SA, Krotova VA. Noninvasive diagnosis of atrophic gastritis by serology. Clinical Laboratory Diagnostics 2007; 11:39-41.
Valle Muňos J, Varasa TA, Pardo RL, Merlo RR, Grueso MJP, Escobedo RM, Torres MA, Boy RC, Jimenez JMC. Diagnóstico serológico de gastritis atrófica con una combibación de pepsinógeno I y II, gastrina-17 y anticuerpos anti-Helicobacter pylori. Gastroenterol Hepatol 2007; 30(10):567-571.
Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 2007; 26:879–887fs
Koivusalo AI, Pakarinen MP, Kolho KL. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children? Diagn Microbiol Infect Dis. 2007; 57(1):35-8. Epub 2006 Sep 1.
Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: Application of plasma biomarkers. Scand J Gastroenterol 2007; 42:2-10.
Suovaniemi O. Biohitin GastroPanel-keksintö Kiinan terveydenhuollon käyttöön. Yksityislääkäri 2007: 1:95-99
van Oijen MGH, Vlemmix F, Laheij RJF, Paloheimo L, Jansen JBMJ, Verheugt FWA. Hyperhomocysteinaemia and Vitamin B12 Deficiency: The Long-Term Effects in Cardiovascular Disease. Cardiology 2007;107: 57-62.
2006
Cao Q, Ran Z, Xiao S. Screening of Atrophic Gastritis and Gastric Cancer Using Serum Pepsinogen, Gastrin-17 and Helicobacter pylori IgG Antibodies. Chin J Gastroenterol 2006;11 (7): 388-394. (In Chinese).
Hoan TK, Paloheimo L, Cam PD, Hop TV. Evaluation of serum pepsinogen and gastrin-17 levels on patients with chronic atrophic gastritis. Tap Chí Khoa Học Tiệu Hóa Việt Nam 2006; 1(3):13-21.
Di Mario F, Cavallaro LG, Moussa AM, Caruana P, Merli R, Maini A, Bertolini S, Dal Bó N, Rugge M, Cavestro GM, Aragona G, Nervi G, Plebani M, Franzé A. Serum pepsinogens in chronic gastritis. Usefulness of serum pepsinogens in H. pylori chronic gastritis: relationship with inflammation, activity and density of the bacterium. DIG DIS SCI 2006, in press.
Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L, Chavez A, Cardenas V. Noninvasive Versus Histologic Detection of Gastric Atrophy an Hispanic Population in North America. Clin Gastroenterol Hepatol 2006; 4:306-314.
Halliday J. Cysteine gum may reduce tobacco, alcohol cancer risk. Published online www.nutraingredients.com, 23 May 2006.
Hopkin M. Chew on this: the gum that fights cancer. Published online www.nature.com, 22 May 2006.
Kuokkanen M, Myllyniemi M, Vauhkonen M, Kääriäinen I, Karesvuori S, Linnala A, Härkönen M, Järvelä I, Sipponen P. A biops-based guick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy 2006;38(7):708-712.
Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME. Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers. Ter Arkh. 2006; 78(2):26-31. [Article in Russian]
Sipponen P. Biomarkers in Clinical practice: a tool to find subjects at high risk fro stomach cancer. A personal view. Advances in Medical Sciences 2006;51;9-11.
2005
Goetze JP, Paloheimo LI, Linnala A, Sipponen P, Palnœs Hansen C, Rehfeld JF. Short report. Gastrin-17 specific antibodies are too specific for gastrinoma diagnosis but stain G-cells. Scand J Gastroenterol 2005; 40:596-598.
Järvinen L. Tapauselostus: GastroPanel - uusi ase dyspepsian turvallisen hoidon kehittämiseen. Yksityislääkäri 2005; 2: 94-98. Also available in English: A new tool for developing a safe treatment for dyspepsia.
Loikkanen S. Lääketieteen Nobel helikobakteeritutkimuksesta. Mahahaava on pian historiaa. KemiaKemi 2005; 8(32): 32-33.
Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, De Rosa G, Budillon. G. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther 2005; 22:1139–1146.
Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN. Non-invasive Diagnosis of Gastric Mucosal Precancerous Changes. 6th International Gastric Cancer Congress IGCC, Yokohama, Japan, 2005 May 4-7. Medimond S.r.l. F504C0631: 329-332.
Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Varvara P, Mernova VP, Polyakova MB. Invasive and non-invasive diagnosis of Helicobacter pylori -associated atrophic gastritis: A comparative study. Scand J Gastroenterol, 2005; 40: 297-301.
Pyurveyeva KV, Lapina TL, Ivashkin VT, Kon'kov MYu, Sklyanskaya OA, Serova AG, Vasil'yeva NYu. Serum pepsinogen I, pepsinogen II and gastrin-17 in diagnostics of atrophic gastritis. RZGGK 2005; 3:48-51.
Sipponen P. Nobel kliiniselle havainnolle, joka mullisti hoitokäytäntöjä. Yksityislääkäri 2005; 6: 25.
Sipponen P, Jauhonen P, Suovaniemi O. GastroPanel dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen. Yksityislääkäri 2005; 6: 95-98.
Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen M. Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol 2005; 11(38): 5988-5992.
Suovaniemi O. Diagnostics to improve evidence-based medicine (EBM). ECL 2005; 24(2):12-13.
Suovaniemi O. GastroPanel - An opportunity to develop the treatment praxis of dyspepsia. ECL 2005; 24(4): 10-11.
Suovaniemi O. GastroPanel-tutkimus dyspepsian, helikobakteeri-infektion ja atrofisen gastriitin ja siihen liittyvien riskien turvallisen tutkimus- ja hoitokäytännön kehittämiseen. TerveysTieto 2005; 5: 18-20.
Suovaniemi O. GastroPanelin käyttö tautien ennaltaehkäisyssä, diagnostiikassa ja seulontatutkimuksissa. TerveysTieto 2005; 1: 36-39.
Suovaniemi O. GastroPanel dyspepsian ja helikobakteeri-infektion turvallisen hoitokäytännön kehittämiseen. Yksityislääkäri 2005; 5: 96-98.
Suovaniemi O. Keksijänä Suomessa. Terveystieto 2005; 4: 4-8. Also available in English: Being an inventor in Finland.
Suovaniemi O, Järvinen L, Sipponen P. GastroPanel-diagnostiikkaa ja seulontaa. Yksityislääkäri 2005; 1:95-98.
2004
Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, Wang X, Wang BL, Miao JY, Ding J, Fan DM. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Dig Dis. 2004;5(1):22-7
Di Mario F, Moussa AM, Cavallaro LG, Caruana P, Merli R, Bertolini S, Iori V, Cavestro GM, Dal Bò N, Pilotto A, Franzé A, Leandro G. Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Digestion 2004; 70:167-172.
Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Boldys H, Romanczyk T. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastro-Enterologica Belgica 2004; Vol. LXVII:320-326.
Kalach N, Legoedec J, Wann A-R, Bergeret M, Dupont C, Raymond J. Serum Levels of Pepsinogen I, Pepsinogen II, and Gastrin-17 in the Course of Helicobacter pylori Gastritis in Pediatrics. Letters to the editor. J Pediatr Gastroenterol Nutr 2004; 39 (5): 568-570.
Pasechnikov V, Chukov S, Kotelevets S, Mostovov A, Mernova V, Polyakova M. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World J Gastroenterol 2004; 10(21): 3146-3150.
Salonen E-M, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere Antibodies in Systemic Lupus Erythematosus (SLE): A Comparison with Five Antinuclear Antibody Assays in 430 Patients with SLE and Other Rheumatic Diseases (Extended report). Ann Rheum Dis 2004; 63: 1250-1254.
Sipponen P, Laxén F, Huotari K, Härkönen M. Atrofiseen gastriittiin liittyvä matala seerumin B12-vitamiinitaso - Vanhenevien miesten terveysriski? Suomen Lääkärilehti 2004; 59/5: 379-384.
Suovaniemi O. GastroPanel in the Screening, Diagnosis and Prevention of Diseases. Hospital Post 4/2004; July-August: 11.
Suovaniemi O. GastroPanelin käyttö seulontatutkimuksissa. Yksityislääkäri 2004; 3:97-98.
Suovaniemi O. GastroPanelin käyttö tautien ennaltaehkäisyssä, diagnostiikassa ja seulontatutkimuksissa. TerveysTieto 2004; 4: 12-15.
Suovaniemi O. New Test Offers Advances in Gastric Diagnosis and Screening. LabMedica International 2004; July-August: 21-24.
Suovaniemi O. The GastroPanel Examination - the Novel Approach to the diagnosis of Helicobacter pylori -infection and Atrophic gastritis from a Blood sample. Innovations in Pharmaceutical Technology, February 2004.
Suovaniemi O. Prueba nueva ofrece avaces en el tamisaje y diagnóstico gástrico. LabMedica en Español 2004; July-August: 21-24.
2003
Baqir HI, Al-Aubaidi MH, Fakhri S, Al-Mousili MM, Hamadi SA. Evaluation of serological tests for the diagnosis of Helicobacter pylori infection. IJGE 2003; 4(1): 41-47.
Broutet N, Plebani M, Sakarovitch C, Sipponen P, Mégraud F, Eurohepygast Study Group. Pepsinogen A, Pepsinogen C, and Gastrin as Makers of Atrophic Chronic Gastritis in European Dyspeptics. British Journal of Cancer 2003; 88: 1239-1247.
Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Dal Bó N, Iori V, Pilotto A, Leandro G, Franze A, Rugge M. "Serological Biopsy" in First Degree Relatives of Patients with Gastric Cancer Affected by Helicobacter pylori Infection. Scand J Gastroenterol 2003;28:1223-1227.
Gøtze JP, Rehfeldt JF. Impact of Assay Epitope Specificity in Gastrinoma Diagnosis. Clin Chem 2003; 49 No 2: 333-4.
Heiniö J. Aggressiivinen innovointi- ja patentointistrategia tie menestykseen, Nesteannostelija- ja instrumenttikeksintöjä, Yksityislääkäri 2003; 1: 96-98.
- Hentola H. Biohit – Kansainvälinen bioteknologiayritys, Yksityislääkäri 2003; 3: 104-106.
Hurme J. Laboratoriotutkimus atrofisen gastriitin toteamisessa. Yksityislääkäri 2003; 4: 98.
Konturek SJ, Konturek PC, Bielanski W, Karczewska E, Zuchowicz M, Hartwich A, Rehfeld JF, Goetze JP, Hahn EG. Serum Progastrin and Its Products, Gastric Acid Secretion and Serum Pepsinogen I in Gastric Cancer. Digestion 2003; 68:169-177.
Kuipers EJ. In through the Out Door: Serology for Atrophic Gastritis, European Journal of Gastroenterology & Hepatology 2003; 15: 877-879.
Laxen F, Sipponen P, Tilvis R. Atrofinen gastriitti – sairaus, joka jää usein vähälle huomiolle. Kliin Lab 2003: 4; 78-81, Yksityislääkäri 2003; 2: 96-98.
Lehtinen P. Testi seuloo terveet ja sairaat mahat. Mediauutiset: 30.5.2003.
Sipponen P, Härkönen M, Alanko A, Suovaniemi O. Diagnosis of Atrophic Gastritis from a Serum Sample. Minerva Gastroenterol Dietol 2003; 49: 11-21.
Sipponen P, Laxen F, Huotari K, Härkönen M. Prevalence of Low Vitamin B-12 and High Homocysteine in Serum in an Elderly Male Population. Associociation with Atrophic Gastritis and H.pylori Infection. Scand J Gastroenterol 2003; Vol 38 (12): 1209-1216.
Suovaniemi O. Determination of H. pylori-related disease. Innovations in Pharmaceutical Technology, September 2003.
Suovaniemi O. Helikobakteeri-infektion ja atrofisen gastriitin sekä siihen liittyvien tautiriskien toteaminen verinäytteestä. Itä-Suomen Lääketiede 23.-25.9.2003, TerveysTieto: 2003; 4: 18-19.
Suovaniemi O, Härkönen M, Paloheimo L, Sipponen P. GastroPanel: Diagnosing Atrophic Gastritis From Serum - Providing a Tool for Evidence-based Medicine. Business Briefing: Global Health Care, 2003, 1-4.
Suovaniemi O, Paloheimo L, Härkönen M, Sipponen P. Atrophic gastritis - a Disease with Significant Clinical Impact. Clinical Note. ECL 2003; 22 (2): 16-19.
Wandzel P, Hartleb M, Waluga M, Matyszczyk B, Boldys H, Romanczyk T. Non-Invasive Diagnosis of Multifocal Atrophic Gastritis. Diagn Lab 2003; 39: 63-72. (In Polish).
Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M, Jussila A, Sipponen P. Non-Endoscopic Diagnosis of Atrophic Gastritis with a Blood Test. Correlation between Gastric Histology and Serum Levels of Gastrin-17 and Pepsinogen I. A Multicenter Study. Eur J Gastroenterol Hepatol 2003; 15: 885-891.
2002
Sipponen P. Gastric Cancer: Pathogenesis, Risks, and Prevention. J Gastroenterol 2002; 37 (Suppl XIII): 39-44.
Sipponen P, Forsblom E, Suovaniemi O, Härkönen M. Application of ELISA assays of pepsinogen I, gastrin-17 and H. pylori antibodies for non-endoscopic diagnosis of atrophic gastritis. Russian J Gastroenterology, Haepatology, Coloproctology 2002; Vol.XII, No.3: 46-51.
Sipponen P, Härkönen M, Alanko A, Suovaniemi O. Diagnosis of Atrophic Gastritis from a Serum Sample. Clin Lab 2002; 48:505-515.
Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M. Serum levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control Study. Scand J Gastroenterol 2002; 37: 785-791.
Suovaniemi O. Atrofisen gastriitin toteaminen verinäytteestä. Yksityislääkäri 2002; 5:77-78.
Suovaniemi O. Biohit innovaatioiden sampo. Yksityislääkäri 2002;4:62-63.
Suovaniemi O. Helikobakteeri-infektion ja atrofisen gastriitin paljastava testipaneeli. Yksityislääkäri 2002;3: 76-79.
Suovaniemi O. Determination of H. pylori -related disease. Innovations in Pharmaceutical Technology 2002; Vol 02 (10): 65-68.
Suovaniemi O. Test Panel for the Determination of Helicobacter pylori -Infection and Atrophic Gastritis. UEMS, Compendium 2002;28-31.
Suovaniemi O, Härkönen, M, Paloheimo LI, Sipponen P. Diagnosis of Atrophic Gastritis from a Serum Sample. Jordan Medical Journal 2002; 2 (Vol 36): 117-121.
2001
Sande N, Nikulin M, Nilsson I, Wadström T, Laxen F, Härkönen M, Suovaniemi O, Sipponen P. Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001; 36:928-933.
Sipponen P. Clinical Reviews. New Techniques. Update on the Pathologic Approach to the Diagnosis of Gastritis, Gastric Atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001; 32(3):196-202.
Sipponen P, Härkönen M, Alanko A. Atrofisen gastriitin toteaminen verinäytteestä. Suomen Lääkärilehti 2001;38:3833-3839.
|
|
|
